type here...

CATEGORIES

Press Release

LATEST

1...101112Page 12 of 12

TRENDING

EDITORS CHOICE

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

Medika Life -
The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

FDA grants yet another EUA for RNA Extraction-Free Covid-19 Assay

Medika Life -
A SARS-CoV-2 diagnostic test which eliminates the costly and time-consuming step of RNA extraction. As opposed to most other molecular assays that rely on RNA extraction and qRT-PCR

Children with no COVID-19 symptoms may shed virus for weeks

Medika Life -
New research suggests that children can shed SARS-CoV-2, the virus that causes COVID-19, even if they never develop symptoms or for long after symptoms have cleared

Hyper-Transmissible SARS-CoV-2 Variant Detected in U.S. Wastewater

Medika Life -
The SARS-CoV-2 B1.1.7 (UK Variant) test is available immediately both as a fee-for-service and as a complete, ready-to-use PCR kit for testing labs.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories